loader image
Saturday, February 22, 2025
43.4 F
McAllen
We Welcome your Press Release
- Advertisement -

Office Of The Governor Statement On COVID-19 Monoclonal Antibody Treatment

Translate to Spanish or other 102 languages!

overnor Abbott’s doctor prescribed Regeneron's monoclonal antibody therapy treatment, which is available at no cost to all Texans who get a doctor’s referral. Image for illustration purposes
Governor Abbott’s doctor prescribed Regeneron’s monoclonal antibody therapy treatment, which is available at no cost to all Texans who get a doctor’s referral. Image for illustration purposes

Mega Doctor News

- Advertisement -

AUSTIN – Office of the Governor Communications Director Mark Miner today issued the following statement:

“Governor Abbott’s doctor prescribed Regeneron’s monoclonal antibody therapy treatment, which is available at no cost to all Texans who get a doctor’s referral. It is recommended that Texans testing positive for COVID-19 seek this antibody therapeutic drug because of its effectiveness to help keep people out of hospitals. Today, the Governor announced the continued expansion of COVID-19 Antibody Infusion Centers across Texas. That is in addition to more than 140 providers that are providing antibody treatment at hospitals and clinics across the state.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Transplant Institute Welcomes Dr. Sridhar Allam, Transplant Nephrologist

Mega Doctor News EDINBURG, Texas - Serving as the only kidney transplant center...

DHR Health Welcomes Dr. Hector Saucedo Crespo, Kidney Transplant Surgeon

Mega Doctor News EDINBURG, Texas - DHR Health, one of the largest physician-owned...

Dr. Francisco Sesatty, Physiatrist, Joins DHR Health to Restore Function & Quality of Life

Mega Doctor News EDINBURG, Texas - DHR Health, the leading healthcare system in...

Expert ENT Care Expands at DHR Health with Four New ENT Specialists

Mega Doctor News McAllen, Harlingen, and Brownsville, Texas: Dedicated to expanding access to...
- Advertisement -
×